Gordon Carl L Insider Trades & Stock Holdings

Director · ADARx Pharmaceuticals, Inc. · Latest filing Sep 28, 2026

Gordon Carl L, Director at ADARx Pharmaceuticals, Inc. has 2 Form 4 trades on file since Sep 21, 2026 across 2 companies. Open-market activity: 2 purchases ($36.15M) and 0 sales ($0), net +$36.15M. Latest filing: acquired 950K shares of $ADRX on Sep 28, 2026 at $17.

Trades on file: 2
Open-market bought: $36.15M
Open-market sold: $0
Net open-market: +$36.15M
Latest filing: Sep 28, 2026

All insider trades by Gordon Carl L

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 28, 2026	$ADRX	Buy (Open-market buy)	950K	$17	$16.15M						Director		—
Sep 21, 2026	$ETRA	Buy (Open-market buy)	1.33M	$15	$20M						Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Gordon Carl L traded

Frequently asked questions

Has Gordon Carl L been buying or selling stock?

Gordon Carl L has 2 open-market purchases and 0 open-market sales on file, net +$36.15M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Gordon Carl L's latest insider trade?

acquired 950K shares of $ADRX on Sep 28, 2026 at $17.

All insiders Insider cluster buys Top insider purchases Latest insider trade news

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text